• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型p53在癌症干细胞中的致癌功能由WIP通过YAP/TAZ调控。

Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.

作者信息

Escoll M, Gargini R, Cuadrado A, Anton I M, Wandosell F

机构信息

Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Nicolás Cabrera 1, Universidad Autónoma Madrid, Madrid, Spain.

Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Valderrebollo 5, Madrid, Spain.

出版信息

Oncogene. 2017 Jun 22;36(25):3515-3527. doi: 10.1038/onc.2016.518. Epub 2017 Feb 6.

DOI:10.1038/onc.2016.518
PMID:28166194
Abstract

Wild-type p53 (wtp53) is described as a tumour suppressor gene; mutations in this gene occur in many human cancers and promote oncogenic capacity. Here, we establish that the oncogenic activity of mutant p53 (mtp53) is driven by the WASP-interacting protein (WIP). WIP knockdown from mtp53-expressing glioblastoma and breast cancer cells (BCC) greatly reduced proliferation and growth capacity of cancer stem cell (CSC)-like cells and decreased CSC-like markers (CD133, CD44 or YAP/TAZ). mtp53 overexpression in human astrocytes enhanced their proliferative capacity in suspension culture and increased expression of CSC markers and WIP. WIP knockdown compromised tumour glioblastoma and BCC growth capacity in vivo. We show that WIP is phosphorylated by AKT2 and is regulated by mtp53/p63 through enhancement of PI3K/AKT2-mediated integrin/receptor recycling pathways. WIP regulates this oncogenic pathway by controlling YAP/TAZ stability. We thus establish a new CSC signalling pathway downstream of mtp53 in which AKT2 regulates WIP and controls YAP/TAZ stability.

摘要

野生型p53(wtp53)被描述为一种肿瘤抑制基因;该基因的突变发生在许多人类癌症中,并促进致癌能力。在此,我们证实突变型p53(mtp53)的致癌活性是由WASP相互作用蛋白(WIP)驱动的。从表达mtp53的胶质母细胞瘤和乳腺癌细胞(BCC)中敲低WIP,可显著降低癌症干细胞(CSC)样细胞的增殖和生长能力,并降低CSC样标志物(CD133、CD44或YAP/TAZ)的表达。在人星形胶质细胞中过表达mtp53可增强其在悬浮培养中的增殖能力,并增加CSC标志物和WIP的表达。敲低WIP会损害体内胶质母细胞瘤和BCC肿瘤的生长能力。我们发现WIP被AKT2磷酸化,并通过增强PI3K/AKT2介导的整合素/受体循环途径受到mtp53/p63的调控。WIP通过控制YAP/TAZ的稳定性来调节这一致癌途径。因此,我们在mtp53下游建立了一条新的CSC信号通路,其中AKT2调节WIP并控制YAP/TAZ的稳定性。

相似文献

1
Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.突变型p53在癌症干细胞中的致癌功能由WIP通过YAP/TAZ调控。
Oncogene. 2017 Jun 22;36(25):3515-3527. doi: 10.1038/onc.2016.518. Epub 2017 Feb 6.
2
WIP-YAP/TAZ as A New Pro-Oncogenic Pathway in Glioma.WIP-YAP/TAZ作为胶质瘤中一种新的促癌途径。
Cancers (Basel). 2018 Jun 9;10(6):191. doi: 10.3390/cancers10060191.
3
WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth.WIP通过YAP/TAZ依赖的自主细胞生长驱动肿瘤进展。
Cell Rep. 2016 Nov 15;17(8):1962-1977. doi: 10.1016/j.celrep.2016.10.064.
4
The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.Hippo 信号转导通路中的 TAZ 和 YAP 在乳腺癌中的致癌作用及其临床意义。
Expert Rev Mol Med. 2015 Jul 2;17:e14. doi: 10.1017/erm.2015.12.
5
OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.OTUB2 通过 Hippo 非依赖性激活 YAP 和 TAZ 促进癌症转移。
Mol Cell. 2019 Jan 3;73(1):7-21.e7. doi: 10.1016/j.molcel.2018.10.030. Epub 2018 Nov 21.
6
Metabolic control of YAP and TAZ by the mevalonate pathway.甲羟戊酸途径对 YAP 和 TAZ 的代谢调控。
Nat Cell Biol. 2014 Apr;16(4):357-66. doi: 10.1038/ncb2936. Epub 2014 Mar 23.
7
STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.STARD13 相关 ceRNA 网络调控 YAP/TAZ 活性抑制通过共调控 Hippo 和 Rho-GTPase/F-actin 信号通路抑制乳腺癌干细胞特性。
J Hematol Oncol. 2018 May 30;11(1):72. doi: 10.1186/s13045-018-0613-5.
8
Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.突变型p53蛋白与Hippo信号转导分子YAP和TAZ:人类癌症中的关键致癌节点
Int J Mol Sci. 2017 May 3;18(5):961. doi: 10.3390/ijms18050961.
9
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.程序性死亡受体配体1(PD-L1)通过激活WIP和β-连环蛋白信号通路促进肿瘤生长和进展,并预示肺癌预后不良。
Cell Death Dis. 2020 Jul 6;11(7):506. doi: 10.1038/s41419-020-2701-z.
10
Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.他汀类药物可抑制失活Hippo信号通路的恶性间皮瘤细胞,并阻断YAP/CD44生长刺激轴。
Cancer Lett. 2017 Jan 28;385:215-224. doi: 10.1016/j.canlet.2016.10.020. Epub 2016 Oct 20.

引用本文的文献

1
Phenotypic variations in glioma stem cells: regulatory mechanisms and implications for therapeutic strategies.胶质瘤干细胞的表型变异:调控机制及其对治疗策略的影响
J Transl Med. 2025 Sep 2;23(1):984. doi: 10.1186/s12967-025-07034-9.
2
Unraveling the role of the WIPF1/ACTN4 complex in podosome formation of human placental EVTs: Insights into recurrent spontaneous abortion.揭示WIPF1/ACTN4复合物在人胎盘绒毛外滋养层细胞足体形成中的作用:对复发性自然流产的见解
Genes Dis. 2025 May 2;12(6):101665. doi: 10.1016/j.gendis.2025.101665. eCollection 2025 Nov.
3
Recent advances in bladder cancer stem cells (BCSCs): A descriptive review of emerging therapeutic targets.

本文引用的文献

1
WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth.WIP通过YAP/TAZ依赖的自主细胞生长驱动肿瘤进展。
Cell Rep. 2016 Nov 15;17(8):1962-1977. doi: 10.1016/j.celrep.2016.10.064.
2
Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway.与纤连蛋白的黏附通过FAK-Src-PI3K途径调节Hippo信号通路。
J Cell Biol. 2015 Aug 3;210(3):503-15. doi: 10.1083/jcb.201501025. Epub 2015 Jul 27.
3
Dual role of YAP and TAZ in renewal of the intestinal epithelium.YAP 和 TAZ 在肠道上皮更新中的双重作用。
膀胱癌干细胞(BCSCs)的最新进展:对新兴治疗靶点的描述性综述。
iScience. 2025 May 22;28(7):112720. doi: 10.1016/j.isci.2025.112720. eCollection 2025 Jul 18.
4
Microcurrent stimulation induces cell death in p53-mutant and 5-FU-resistant breast cancer.微电流刺激可诱导p53基因发生突变且对5-氟尿嘧啶耐药的乳腺癌细胞死亡。
J Biol Chem. 2025 Jun 24;301(8):110414. doi: 10.1016/j.jbc.2025.110414.
5
WIPF1 regulates stemness in small cell lung cancer.WIPF1调节小细胞肺癌中的干性。
Sci Prog. 2025 Apr-Jun;108(2):368504251345012. doi: 10.1177/00368504251345012. Epub 2025 May 25.
6
Natural compound PEITC inhibits gain of function of p53 mutants in cancer cells by switching YAP-binding partners between p53 and p73.天然化合物PEITC通过在p53和p73之间切换YAP结合伴侣来抑制癌细胞中p53突变体的功能获得。
Acta Pharmacol Sin. 2025 Jun;46(6):1722-1732. doi: 10.1038/s41401-025-01474-1. Epub 2025 Feb 10.
7
Multifaceted role of the actin-binding protein WIP: Promotor and inhibitor of tumor progression and dissemination.肌动蛋白结合蛋白WIP的多方面作用:肿瘤进展和扩散的促进者与抑制剂
Cytoskeleton (Hoboken). 2025 Mar;82(3):186-196. doi: 10.1002/cm.21935. Epub 2024 Sep 27.
8
CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation-Mediated c-Myc Deubiquitylation to Facilitate Mutant TP53 Transcription.环状 RNA CFL1 通过去乙酰化介导的 c-Myc 去泛素化促进三阴性乳腺癌干性和免疫逃逸,从而促进突变型 TP53 转录。
Adv Sci (Weinh). 2024 Sep;11(34):e2404628. doi: 10.1002/advs.202404628. Epub 2024 Jul 9.
9
Cancer stem cells: advances in knowledge and implications for cancer therapy.癌症干细胞:知识进展及其对癌症治疗的影响。
Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y.
10
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.p53 调控的细胞命运:癌症治疗中的朋友还是可逆的敌人?
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
Nat Cell Biol. 2015 Jan;17(1):7-19. doi: 10.1038/ncb3084. Epub 2014 Dec 22.
4
Cancer stem cell-like phenotype and survival are coordinately regulated by Akt/FoxO/Bim pathway.癌症干细胞样表型与生存由Akt/FoxO/Bim信号通路协同调控。
Stem Cells. 2015 Mar;33(3):646-60. doi: 10.1002/stem.1904.
5
The biology of YAP/TAZ: hippo signaling and beyond.YAP/TAZ 的生物学: Hippo 信号通路及其他。
Physiol Rev. 2014 Oct;94(4):1287-312. doi: 10.1152/physrev.00005.2014.
6
WIP is necessary for matrix invasion by breast cancer cells.工作进展对于乳腺癌细胞的基质侵袭是必要的。
Eur J Cell Biol. 2014 Oct;93(10-12):413-23. doi: 10.1016/j.ejcb.2014.07.008. Epub 2014 Aug 7.
7
YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.YAP/TAZ 与 β-连环蛋白降解复合物的结合调控 Wnt 反应。
Cell. 2014 Jul 3;158(1):157-70. doi: 10.1016/j.cell.2014.06.013. Epub 2014 Jun 26.
8
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling.突变型 p53 通过细胞自主 PDGF 受体 β 信号促进胰腺癌转移。
Cell. 2014 Apr 10;157(2):382-394. doi: 10.1016/j.cell.2014.01.066.
9
Metabolic control of YAP and TAZ by the mevalonate pathway.甲羟戊酸途径对 YAP 和 TAZ 的代谢调控。
Nat Cell Biol. 2014 Apr;16(4):357-66. doi: 10.1038/ncb2936. Epub 2014 Mar 23.
10
Contribution of p53 to metastasis.p53对转移的作用。
Cancer Discov. 2014 Apr;4(4):405-14. doi: 10.1158/2159-8290.CD-13-0136. Epub 2014 Mar 21.